
Oncology
Prostate Cancer: HRR Testing Defines Talazoparib Use
The verified FDA indication covers adults with HRR gene-mutated metastatic castration-resistant prostate cancer, making an approved companion diagnostic essential before talazoparib plus enzalutamide.
Dr. Abu Bakar · November 8, 2026 · 6 min
